Gloria Melanie 4

What Happened

• Gloria Melanie, Chief Operating Officer of Immunovant, sold a total of 17,714 shares in two open-market transactions on June 26, 2026, generating approximately $678,605 in proceeds.
  • 14,748 shares sold at a weighted-average price of $38.18 for proceeds of $563,079 (shares sold across prices $37.77–$38.56).
  • 2,966 shares sold at a weighted-average price of $38.95 for proceeds of $115,526 (shares sold across prices $38.78–$39.13).

Key Details

• Transaction date: 2026-06-26 (reported on Form 4 filed 2026-06-26).
• Transaction type: Sale (Code S) — open-market disposals.
• Total shares sold: 17,714; Total proceeds: ~$678,605.
• Weighted-average prices reported; footnotes state the shares were sold in multiple trades across the specified price ranges and that the reporting person will provide a breakdown on request.
• Shares owned after transaction: not disclosed in the provided filing.
• No 10b5-1 plan, tax withholding, or other special plan references were noted in the provided excerpt.

Context

• This filing documents insider sales, which are often routine (e.g., diversification or liquidity needs) and do not by themselves indicate management views on company fundamentals. Retail investors should consider these sales alongside other insider activity, company fundamentals, and broader market activity.